Related Experiment Video

Updated: Sep 26, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Paediatric community-acquired pneumonia: current concept in pharmacological control

Nicola Principi1, Susanna Esposito

  • 1Paediatric Department I, University of Milan, Via Commenda 9, 20122 Milano, Italy. Nicola.Principi@unimi.it

Expert Opinion on Pharmacotherapy
|May 13, 2003
PubMed

Insights

Community-acquired pneumonia (CAP) in children is common, but treatment is challenging due to unknown causes and antibiotic resistance. Developing consensus guidelines is crucial to avoid overuse of antibiotics and combat resistance.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Community-acquired pneumonia (CAP) is a leading childhood infection.
  • Challenges in CAP management include etiological diagnosis, rising antibiotic resistance in common pathogens, and unclear vaccine efficacy.
  • Current practice often involves broad-spectrum antibiotic combinations for most pediatric CAP cases.

Purpose of the Study:

  • To highlight the complexities in managing pediatric CAP.
  • To emphasize the need for evidence-based guidelines to optimize treatment.
  • To advocate for strategies that reduce unnecessary antibiotic exposure and mitigate antibiotic resistance.

Main Methods:

  • Review of current challenges in pediatric CAP diagnosis and treatment.
  • Analysis of factors contributing to antibiotic resistance.
  • Discussion of the role of preventive strategies like conjugate vaccines.

Main Results:

  • Etiological diagnosis of CAP in children remains difficult.
  • Increasing antibiotic resistance necessitates careful treatment selection.
  • Lack of definitive data on conjugate vaccine impact complicates prevention strategies.

Conclusions:

  • Pediatric CAP management requires a rational therapeutic approach.
  • Consensus guidelines are essential for appropriate antibiotic use in CAP.
  • Implementing guidelines can help prevent unnecessary antibiotic prescriptions and curb resistance spread.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...